Spotlight Innovation Becomes Member of Iowa Biotechnology Association

WEST DES MOINES, IA--(Marketwired - May 12, 2015) - Spotlight Innovation Inc. (OTCQB: STLT) announces today that it has become a member of the Iowa Biotechnology Association. The Association was founded to unify Iowa's bioscience industry, academic research institutions and economic development organizations, and to foster a strong business and research climate that attracts and retains bioscience talent, companies and funding.

Cris Grunewald, President and CEO of Spotlight Innovation, said, "The Iowa Biotechnology Association does outstanding work for Iowa-based biotech companies like ours, helping to ensure that our state remains a leader in innovation. We look forward to a long affiliation with this essential organization."

Said Joe Hrdlicka, Executive Director of the Iowa Biotechnology Association, "We're excited to have Spotlight Innovation join our organization with its unique approach to supporting growth in this industry so critical to improving the quality-of-life in Iowa."

About Spotlight Innovation Inc.

Spotlight Innovation Inc. (OTCQB: STLT) specializes in identifying, acquiring and incubating companies that have unique intellectual property (IP) in the medical sector. The Company utilizes relationships with the nation's leading academic and institutional IP developers to locate promising IP technologies with potential for market share capture. With our support, development, resources and strategic planning expertise, we believe we can develop IP that will have a positive effect on healthcare. We intend to partner with proven sector leaders on commercialization once technologies are fully developed. Additional information available at www.spotlightinnovation.com.

About the Iowa Biotechnology Association

The Iowa Biotechnology Association, a 501(c)6 non-profit trade association, was founded in 1994 to unify Iowa's bioscience industry, academic research institutions and economic development organizations. The Iowa Biotechnology Association represents more than 90 members spanning across the state, who are vested in Iowa and in the biotech industry. More information at iowabio.org.

Forward Looking Statements

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.